The Defense Logistics Agency (DLA) is soliciting offers for Potassium Chloride Extended Release Tablets under solicitation number SPE2D2-24-R-0013. This procurement aims to acquire pharmaceutical products in various quantities, ensuring that suppliers meet federal standards for quality and compliance. Potassium Chloride is a critical medication used for treating and preventing potassium deficiency, highlighting the importance of reliable supply in healthcare settings. Interested vendors must submit their proposals electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS) by the deadline of October 10, 2024. For further inquiries, potential bidders can contact Ryan Guarnere at ryan.guarnere@dla.mil or Jason Wray at jason.wray@dla.mil.